Willie Quinn | CFO and SVP, Finance and Corporate Development |
Dayton Misfeldt | Interim CEO |
Judy Fox | Chief Scientific Officer |
Debbie Thomas | SVP, Regulatory Affairs |
Eric Schmidt | Cowen & Company |
Nick Abbott | Wells Fargo |
Hartaj Singh | Oppenheimer & Co. Inc. |
Mara Goldstein | Cantor Fitzgerald |
Welcome to Sunesis Pharmaceuticals Fourth Quarter and Year-End 2017 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to Willie Quinn, Chief Financial Officer and Senior Vice President, Corporate Development.